The U.S. Department of Justice put the pharmaceutical and medical device industries on notice in November 2009. In the months and years ahead, the DOJ said, it would be targeting those industries for violations of the Foreign Corrupt Practices Act, ...
Tagged with: Sept. 30 2012 issue
Read More »